Literature DB >> 6181929

Antigenic variants of rabies virus.

K M Charlton, G A Casey, D W Boucher, T J Wiktor.   

Abstract

The authors studied nineteen street virus isolates from different regions of Canada using either anti-nucleocapsid and anti-glycoprotein monoclonal antibodies or cross-protection tests. This study only allowed us to recognize three groups of viruses with different nucleocapsid patterns, and no difference, as far as protection with a Pitmann-Moore vaccine is concerned, between four of these strains.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6181929     DOI: 10.1016/0147-9571(82)90023-6

Source DB:  PubMed          Journal:  Comp Immunol Microbiol Infect Dis        ISSN: 0147-9571            Impact factor:   2.268


  6 in total

1.  An epidemic of sylvatic rabies in Finland--descriptive epidemiology and results of oral vaccination.

Authors:  M Nyberg; K Kulonen; E Neuvonen; C Ek-Kommonen; M Nuorgam; B Westerling
Journal:  Acta Vet Scand       Date:  1992       Impact factor: 1.695

2.  Raccoon rabies in eastern Canada (1963 to 1994): a retrospective report.

Authors:  G A Casey; A I Wandeler; K M Charlton
Journal:  Can Vet J       Date:  1996-06       Impact factor: 1.008

3.  Antigenic variants of rabies virus in isolates from eastern, central and northern Canada.

Authors:  W A Webster; G A Casey; K M Charlton; T J Wiktor
Journal:  Can J Comp Med       Date:  1985-04

4.  Enzyme immunoassay for rabies antibody in hybridoma culture fluids and its application to differentiation of street and laboratory strains of rabies virus.

Authors:  J S Smith; J W Sumner; L F Roumillat
Journal:  J Clin Microbiol       Date:  1984-02       Impact factor: 5.948

5.  Cross-protection of mice against a global spectrum of rabies virus variants.

Authors:  D L Lodmell; J S Smith; J J Esposito; L C Ewalt
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

Review 6.  The application of monoclonal antibodies in the study of viruses.

Authors:  M J Carter; V ter Meulen
Journal:  Adv Virus Res       Date:  1984       Impact factor: 9.937

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.